Detalhe da pesquisa
1.
Combination immunotherapy including OncoVEXmGMCSF creates a favorable tumor immune micro-environment in transgenic BRAF murine melanoma.
Cancer Immunol Immunother
; 71(8): 1837-1849, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-34999916
2.
Etiologies of Melanoma Development and Prevention Measures: A Review of the Current Evidence.
Cancers (Basel)
; 13(19)2021 Sep 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-34638397